FDA Inspection 1236732 — Nivagen Pharmaceuticals Inc
The FDA completed an inspection of Nivagen Pharmaceuticals Inc on Mar 20, 2024 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 20, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sacramento, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)